A Study of Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine
Clinical trial NCT03900572 · COMPLETED
Trial details
- NCT number
- NCT03900572
- Sponsor
- Shanghai Zerun Biotechnology Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-09
- Primary completion
- 2020-04-30
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.